klucel™ xtend hydroxypropylcellulose (HPC) controlled release matrix former

Ashland introduces Klucel™ xtend hydroxypropyl cellulose (HPC) controlled release matrix former, designed to deliver unsurpassed process versatility and release profile efficiency. It is the latest addition to our Klucel™ product line and further expands our controlled-release portfolio.

Until now, there were limited options for managing the release profile of formulations, especially high dose, controlled release formulations. Ashland’s step change klucel™ xtend HPC has been shown to match the release profile of hypromellose controlled-release formulations at half the polymer concentration. The highly reduced polymer concentration achievable with klucel™ xtend HPC offers the possibility of smaller pills or higher dosage, if necessary. This new excipient offers unrivaled versatility across a broad range of APIs in every manufacturing process: dry granulation, wet-granulation, direct compression, and holt-melt extrusion.

The need for hot-melt extrusion (HME) polymers is expected to grow as the pharma industry moves to implement more continuous and sustainable processes. klucel™ xtend HPC is the only cellulosic excipient that provides a compendial extended-release polymer option for plasticizer-free HME.

This oral matrix former is the new gold standard for extended-release tablets.

klucel™ xtend HPC extending your options for

  • highly soluble APIs
  • high drug load formulations
  • melt granulation or HME processing
  • increased patient compliance
  • complex formulations

features

  • high gel strength
  • low melt processing temperature
  • process versatility

benefits

  • consistent release profiles at lower concentrations than hydroxypropyl methylcellulose (HPMC)
  • reduced burst effect in highly soluble APIs
  • enables the development of smaller tablets and improves consumer usability
  • excellent performance in direct compression, wet granulation, dry granulation, and hot melt extrusion
  • plasticizer-free HME processability
  • meets all compendia for HPC

And submit the literature download form on the right to download more information and data about klucel™ xtend HPC. 

Read More >

additional content coming soon

additional content coming soon

additional content coming soon

additional content coming soon

iSolve-Web-Promo-Graphic-Pharma.jpg

Want more information?

view our klucel™ xtend webinar

klucel™ xtend HPC: New hydrophilic matrix polymer addresses the limitations of traditional hypromellose polymers

Learn how Ashland’s step change hydroxypropyl cellulose, klucel™ xtend hpc, has been shown to match the release profile of widely used hypromellose controlled-release formulations at half the polymer concentration.

visit with us about Klucel xtend™ hpc at: 

  • AAPS 2023 October 22-25, Orange Country Convention Center, Orlando, FL, Booth 2701

other related links